Cellular Biomedicine Group (CBMG) Tops Q1 EPS by 1c

Cellular Biomedicine Group (NASDAQ: CBMG) reported Q1 EPS of ($0.39), $0.01 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $603.4 thousand, versus $61.1 thousand reported last year.

For earnings history and earnings-related data on Cellular Biomedicine Group (CBMG) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M